Heteroaryl quinolines as inhibitors of leukotriene biosynthesis
US5410054A · kind A · utility
0Cited by
19References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 20, 1993 |
| Grant date | Apr 25, 1995 |
| Priority date | — |
| Expiry date | Jul 20, 2013 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D493/08
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Compounds having the formula I: ##STR1## are inhibitors of leukotriene biosynthesis. These compounds are useful as anti-asthmatic, anti-allergic, anti-inflammatory, and cytoprotective agents. They are also useful in treating angina, cerebral spasm, glomerular nephritis, hepatitis, endotoxemia, uveitis, and allograft rejection and in preventing the formation of atherosclerotic plaques.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.